208 related articles for article (PubMed ID: 8729520)
1. Heterogeneous distribution of thyrotrophin receptor messenger ribonucleic acid (TSH-R mRNA) in papillary thyroid carcinomas detected by in situ hybridization.
Tanaka K; Inoue H; Miki H; Komaki K; Monden Y
Clin Endocrinol (Oxf); 1996 Mar; 44(3):259-67. PubMed ID: 8729520
[TBL] [Abstract][Full Text] [Related]
2. Thyroid transcription factor-1 in normal, hyperplastic, and neoplastic follicular thyroid cells examined by immunohistochemistry and nonradioactive in situ hybridization.
Katoh R; Kawaoi A; Miyagi E; Li X; Suzuki K; Nakamura Y; Kakudo K
Mod Pathol; 2000 May; 13(5):570-6. PubMed ID: 10824930
[TBL] [Abstract][Full Text] [Related]
3. Expressions of human sodium iodide symporter mRNA in primary and metastatic papillary thyroid carcinomas.
Park HJ; Kim JY; Park KY; Gong G; Hong SJ; Ahn IM
Thyroid; 2000 Mar; 10(3):211-7. PubMed ID: 10779135
[TBL] [Abstract][Full Text] [Related]
4. Expression of thyrotropin receptor (TSH-R), thyroglobulin, thyroperoxidase, and calcitonin messenger ribonucleic acids in thyroid carcinomas: evidence of TSH-R gene transcript in medullary histotype.
Elisei R; Pinchera A; Romei C; Gryczynska M; Pohl V; Maenhaut C; Fugazzola L; Pacini F
J Clin Endocrinol Metab; 1994 Apr; 78(4):867-71. PubMed ID: 8157713
[TBL] [Abstract][Full Text] [Related]
5. Expression of thyrotrophin receptor gene in thyroid carcinoma is associated with a good prognosis.
Shi Y; Zou M; Farid NR
Clin Endocrinol (Oxf); 1993 Sep; 39(3):269-74. PubMed ID: 8222289
[TBL] [Abstract][Full Text] [Related]
6. FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance.
McIver B; Grebe SK; Wang L; Hay ID; Yokomizo A; Liu W; Goellner JR; Grant CS; Smith DI; Eberhardt NL
Clin Endocrinol (Oxf); 2000 Jun; 52(6):749-57. PubMed ID: 10848880
[TBL] [Abstract][Full Text] [Related]
7. Rapid detection of specific messenger RNAs in thyroid carcinomas by reverse transcription-PCR with degenerate primers: specific expression of oncofetal fibronectin messenger RNA in papillary carcinoma.
Takano T; Matsuzuka F; Sumizaki H; Kuma K; Amino N
Cancer Res; 1997 Sep; 57(17):3792-7. PubMed ID: 9288789
[TBL] [Abstract][Full Text] [Related]
8. Inverse correlation between heparan sulfate composition and heparanase-1 gene expression in thyroid papillary carcinomas: a potential role in tumor metastasis.
Xu X; Quiros RM; Maxhimer JB; Jiang P; Marcinek R; Ain KB; Platt JL; Shen J; Gattuso P; Prinz RA
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5968-79. PubMed ID: 14676122
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical loss of thyroid peroxidase in papillary thyroid carcinoma: strong suppression of peroxidase gene expression.
Tanaka T; Umeki K; Yamamoto I; Sugiyama S; Noguchi S; Ohtaki S
J Pathol; 1996 May; 179(1):89-94. PubMed ID: 8691351
[TBL] [Abstract][Full Text] [Related]
10. Detection of laminin receptor mRNA in human cancer cell lines and colorectal tissues by in situ hybridization.
Campo E; Monteagudo C; Castronovo V; Claysmith AP; Fernandez PL; Sobel ME
Am J Pathol; 1992 Nov; 141(5):1073-83. PubMed ID: 1443045
[TBL] [Abstract][Full Text] [Related]
11. In situ detection of hTERT mRNA relates to Ki-67 labeling index in papillary thyroid carcinoma.
Chou SJ; Chen CM; Harn HJ; Chen CJ; Liu YC
J Surg Res; 2001 Jul; 99(1):75-83. PubMed ID: 11421607
[TBL] [Abstract][Full Text] [Related]
12. E-cadherin: a differentiation marker in thyroid malignancies.
Brabant G; Hoang-Vu C; Cetin Y; Dralle H; Scheumann G; Mölne J; Hansson G; Jansson S; Ericson LE; Nilsson M
Cancer Res; 1993 Oct; 53(20):4987-93. PubMed ID: 8402689
[TBL] [Abstract][Full Text] [Related]
13. Expression of parathyroid hormone-related peptide in human thyroid tumours.
Nakashima M; Ohtsuru A; Luo WT; Nakayama T; Enomoto H; Usa T; Kiriyama T; Ito M; Nagataki S; Yamashita S
J Pathol; 1995 Feb; 175(2):227-36. PubMed ID: 7738719
[TBL] [Abstract][Full Text] [Related]
14. Expression of thyrotropin receptor and thyroid hormone receptor messenger ribonucleic acid in normal, hyperplastic, and neoplastic human thyroid tissue.
Brönnegård M; Törring O; Böös J; Sylven C; Marcus C; Wallin G
J Clin Endocrinol Metab; 1994 Aug; 79(2):384-9. PubMed ID: 8045952
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications.
Chevillard S; Ugolin N; Vielh P; Ory K; Levalois C; Elliott D; Clayman GL; El-Naggar AK
Clin Cancer Res; 2004 Oct; 10(19):6586-97. PubMed ID: 15475448
[TBL] [Abstract][Full Text] [Related]
16. Relationship between prognostic score and thyrotropin receptor (TSH-R) in papillary thyroid carcinoma: immunohistochemical detection of TSH-R.
Tanaka K; Inoue H; Miki H; Masuda E; Kitaichi M; Komaki K; Uyama T; Monden Y
Br J Cancer; 1997; 76(5):594-9. PubMed ID: 9303357
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical and in situ hybridization analyses of midkine expression in thyroid papillary carcinoma.
Kato M; Maeta H; Kato S; Shinozawa T; Terada T
Mod Pathol; 2000 Oct; 13(10):1060-5. PubMed ID: 11048798
[TBL] [Abstract][Full Text] [Related]
18. Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue.
Fernández PL; Merino MJ; Gómez M; Campo E; Medina T; Castronovo V; Sanjuán X; Cardesa A; Liu FT; Sobel ME
J Pathol; 1997 Jan; 181(1):80-6. PubMed ID: 9072007
[TBL] [Abstract][Full Text] [Related]
19. Expression of Met protein and urokinase-type plasminogen activator receptor (uPA-R) in papillary carcinoma of the thyroid.
Zanetti A; Stoppacciaro A; Marzullo A; Ciabatta M; Fazioli F; Prat M; Comoglio PM; Baroni CD; Ruco LP
J Pathol; 1998 Nov; 186(3):287-91. PubMed ID: 10211118
[TBL] [Abstract][Full Text] [Related]
20. Expression of the Na+/I- symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes.
Lazar V; Bidart JM; Caillou B; Mahé C; Lacroix L; Filetti S; Schlumberger M
J Clin Endocrinol Metab; 1999 Sep; 84(9):3228-34. PubMed ID: 10487692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]